Minireview: Translocator protein (TSPO) and steroidogenesis: A reappraisal

Molecular Endocrinology

Volumn 29, Issue 4, 2015, Pages 490-501

  Selvaraj, Vimal ^a   Stocco, Douglas M ^b   Tu, Lan N ^a  

^a Department of Obstetrics Gynecology   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

18 KDA TRANSLOCATOR PROTEIN; BENZODIAZEPINE RECEPTOR; DIAZEPAM BINDING INHIBITOR; MEMBRANE PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RO5 4864; STEROID HORMONE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; CHOLESTEROL; SEX HORMONE; TSPO PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ARTICLE; CHOLESTEROL TRANSPORT; DIMERIZATION; DNA POLYMORPHISM; FATTY ACID METABOLISM; GENE DISRUPTION; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STEROIDOGENESIS; ANIMAL; BIOSYNTHESIS; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; GONADAL STEROID HORMONES; HUMANS; RECEPTORS, GABA;

EID: 84926316945     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1033     Document Type: Article

References (126)

1. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977;269: 702-704.
2. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci USA. 1977;74:3805-3809.
3. Regan JW, Yamamura HI, Yamada S, Roeske WR. High affinity [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension. Life Sci. 1981;28:991-998.
4. Davies LP, Huston V. Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Eur J Pharmacol. 1981;73:209-211.
5. Takahashi H, Nagashima A, Koshino C. Effect of _-aminobutyrylcholine upon the electrical activity of the cerebral cortex. Nature. 1958;182:1443-1444.
6. Macdonald R, Barker JL. Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature. 1978;271:563-564.
7. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629-650.
8. Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971-988.
9. Gatliff J, Campanella M. The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med. 2012; 12:356-368.
10. Le Fur G, Perrier ML, Vaucher N, et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 1983;32:1839-1847.
11. Benavides J, Malgouris C, Imbault F, et al. “Peripheral type” benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Arch Int Pharmacodyn Ther. 1983;266:38-49.
12. Le Fur G, Vaucher N, Perrier ML, et al. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci. 1983;33:449-457.
13. Bénavidès J, Guilloux F, Allam DE, et al. Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice. Life Sci. 1984;34:2613-2620.
14. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1-17.
15. Banati RB, Newcombe J, Gunn RN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123(pt 11):2321-2337.
16. Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008; 35:2304-2319.
17. Yeliseev AA, Kaplan S. A sensory transducer homologous to the mammalian peripheral-type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J Biol Chem. 1995;270:21167-21175.
18. Yeliseev AA, Krueger KE, Kaplan S. A mammalian mitochondrial drug receptor functions as a bacterial “oxygen” sensor. Proc Natl Acad Sci USA. 1997;94:5101-5106.
19. Riond J, Mattei MG, Kaghad M, et al. Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur J Biochem. 1991;195:305-311.
20. Bucan M, Gatalica B, Nolan P, et al. Comparative mapping of 9 human chromosome 22q loci in the laboratory mouse. Hum Mol Genet. 1993;2:1245-1252.
21. Anholt RR, De Souza EB, Oster-Granite ML, Snyder SH. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther. 1985;233:517-526.
22. Wang HJ, Fan J, Papadopoulos V. Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription. Cell Tissue Res. 2012;350:261-275.
23. Tu LN, Morohaku K, Manna PR, et al. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem. 2014;289:27444-27454.
24. Morohaku K, Phuong NS, Selvaraj V. Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues. PLoS One. 2013;8:e74509.
25. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheraltype benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986;261:576-583.
26. Basile AS, Skolnick P. Subcellular localization of “peripheraltype” binding sites for benzodiazepines in rat brain. J Neurochem. 1986;46:305-308.
27. Olson JM, Ciliax BJ, Mancini WR, Young AB. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol. 1988;152:47-53.
28. Oke BO, Suarez-Quian CA, Riond J, Ferrara P, Papadopoulos V. Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol Cell Endocrinol. 1992;87: R1-R6.
29. Manku G, Wang Y, Thuillier R, Rhodes C, Culty M. Developmental expression of the translocator protein 18 kDa (TSPO) in testicular germ cells. Curr Mol Med. 2012;12:467-475.
30. Venturini I, Zeneroli ML, Corsi L, et al. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 1998;63:1269-1280.
31. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell pro-liferation and nuclear transport of cholesterol. Cancer Res. 1999; 59:831-842.
32. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenylmethylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol. 2008; 74:443-453.
33. Seneviratne MS, Faccenda D, De Biase V, Campanella M. PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knock-down cells. Curr Mol Med. 2012;12:476-482.
34. Guillaumot D, Guillon S, Déplanque T, et al. The Arabidopsis TSPO-related protein is a stress and abscisic acid-regulated, endoplasmic reticulum-Golgi-localized membrane protein. Plant J. 2009;60:242-256.
35. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA. 1989;86:9813-9816.
36. Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem. 1990;265:3772-3779.
37. Churchill PF, Kimura T. Topological studies of cytochromes P-450scc and P-45011 β in bovine adrenocortical inner mitochondrial membranes. Effects of controlled tryptic digestion. J Biol Chem. 1979;254:10443-10448.
38. Cheng B, Hsu DK, Kimura T. Utilization of intramitochondrial membrane cholesterol by cytochrome P-450-dependent cholesterol side-chain cleavage reaction in bovine adrenocortical mitochondria: steroidogenic and non-steroidogenic pools of cholesterol in the mitochondrial inner membranes. Mol Cell Endocrinol. 1985;40:233-243.
39. Rennert H, Cheng YJ, Strauss JF III. Intracellular cholesterol dynamics in steroidogenic cells: a contemporary view. In: Adashi EY LP, ed. The Ovary. New York, NY: Raven Press;1993:147-164.
40. Ferguson JJ Jr. Protein synthesis and adrenocorticotropin responsiveness. J Biol Chem. 1963;238:2754-2759.
41. Garren LD, Ney RL, Davis WW. Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo. Proc Natl Acad Sci USA. 1965; 53:1443-1450.
42. Vahouny GV, Chanderbhan R, Kharroubi A, Noland BJ, Pastuszyn A, Scallen TJ. Sterol carrier and lipid transfer proteins. Adv Lipid Res. 1987;22:83-113.
43. Pedersen RC, Brownie AC. Cholesterol side-chain cleavage in the rat adrenal cortex: isolation of a cycloheximide-sensitive activator peptide. Proc Natl Acad Sci USA. 1983;80:1882-1886.
44. Pedersen RC, Brownie AC. Steroidogenesis-activator polypeptide isolated from a rat Leydig cell tumor. Science. 1987;236:188-190.
45. Seedorf U, Raabe M, Ellinghaus P, et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 1998;12:1189-1201.
46. Li XA, Warren DW, Gregoire J, Pedersen RC, Lee AS. The rat 78,000 dalton glucose-regulated protein (GRP78) as a precursor for the rat steroidogenesis-activator polypeptide (SAP): the SAP coding sequence is homologous with the terminal end of GRP 78. Mol Endocrinol. 1989;3:1944-1952.
47. Wang M, Wey S, Zhang Y, Ye R, Lee AS. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal. 2009;11: 2307-2316.
48. Luo S, Mao C, Lee B, Lee AS. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol Cell Biol. 2006; 26:5688-5697.
49. Wey S, Luo B, Tseng CC, et al. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling. Blood. 2012;119:817-825.
50. Wisniewska M, Karlberg T, Lehtio L, et al. Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/ Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B’, and HSPA5/ BiP/GRP 78. PLoS One. 2010;5:e8625.
51. Krueger RJ, Orme-Johnson NR. Acute adrenocorticotropic hormone stimulation of adrenal corticosteroidogenesis. Discovery of a rapidly induced protein. J Biol Chem. 1983;258:10159-10167.
52. Pon LA, Hartigan JA, Orme-Johnson NR. Acute ACTH regulation of adrenal corticosteroid biosynthesis. Rapid accumulation of a phosphoprotein. J Biol Chem. 1986;261:13309-13316.
53. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314-28322.
54. Lin D, Sugawara T, Strauss JF 3rd, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995;267:1828-1831.
55. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA. 1997;94:11540-11545.
56. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol. 2000;7:408-414.
57. Papadopoulos V, Berkovich A, Krueger KE. The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: regulation of steroid biosynthesis. Neuropharmacology. 1991;30:1417-1423.
58. Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 1991;129: 1481-1488.
59. Papadopoulos V, Guarneri P, Kreuger KE, Guidotti A, Costa E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci USA. 1992;89:5113-5117.
60. Garnier M, Boujrad N, Oke BO, et al. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. 1993;132:444-458.
61. Kelly-Hershkovitz E, Weizman R, Spanier I, et al. Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J Biol Chem. 1998;273:5478-5483.
62. Hauet T, Yao ZX, Bose HS, et al. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol. 2005;19:540-554.
63. Garnier M, Boujrad N, Ogwuegbu SO, Hudson JR Jr, Papadopoulos V. The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1994;269:22105-22112.
64. Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1997;272:32129-32135.
65. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA. 2001;98:1267-1272.
66. Papadopoulos V, Amri H, Boujrad N, et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids. 1997;62:21-28.
67. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol. 2001;63:193-213.
68. Arakane F, Sugawara T, Nishino H, et al. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci USA. 1996;93:13731-13736.
69. Wang X, Liu Z, Eimerl S, et al. Effect of truncated forms of the steroidogenic acute regulatory protein on intramitochondrial cholesterol transfer. Endocrinology. 1998;139:3903-3912.
70. Bose HS, Lingappa VR, Miller WL. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature. 2002;417: 87-91.
71. Papadopoulos V, Miller WL. Role of mitochondria in steroidogenesis. Best Pract Res Clin Endocrinol Metab. 2012;26:771-790.
72. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology. 2014;155:89-97.
73. Tu LN, Zhao AH, Stocco DM, Selvaraj V. PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO). Endocrinology 2014:en20141707.
74. Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des. 2007;13:2385-2405.
75. Amri H, Culty M, Gaillard JL, Teper G, Papadopoulos V. The peripheral-type benzodiazepine receptor and adrenal steroidogenesis. Curr Opin Endocrinol Diabetes. 1999;6:179-184.
76. Banati RB, Middleton RJ, Chan R, et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat Commun. 2014;5:5452.
77. Anholt RR, De Souza EB, Kuhar MJ, Snyder SH. Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur J Pharmacol. 1985;110:41-46.
78. Deane HW, Greep RO. A morphological and histochemical study of the rat’s adrenal cortex after hypoph ysectomy, with comments on the liver. Am J Anat. 1946;79:117-145.
79. Kimura T. Effects of hypophysectomy and ACTH administration on the level of adrenal cholesterol side-chain desmolase. Endocrinology. 1969;85:492-499.
80. Cavallaro S, Pani L, Guidotti A, Costa E. ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action. Life Sci. 1993;53:1137-1147.
81. Hatty CR, Le Brun AP, Lake V, et al. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers. Biochim Biophys Acta. 2014;1838:1019-1030.
82. Farges R, Joseph-Liauzun E, Shire D, Caput D, Le Fur G, Ferrara P. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. Mol Pharmacol. 1994;46:1160-1167.
83. Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science. 2014;343:1363-1366.
84. Cavallaro S, Korneyev A, Guidotti A, Costa E. Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland. Proc Natl Acad Sci USA. 1992; 89:10598-10602.
85. Romeo E, Cavallaro S, Korneyev A, et al. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex. J Pharmacol Exp Ther. 1993;267:462-471.
86. Korneyev A, Pan BS, Polo A, Romeo E, Guidotti A, Costa E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J Neurochem. 1993;61:1515-1524.
87. Auta J, Romeo E, Kozikowski A, Ma D, Costa E, Guidotti A. Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther. 1993;265:649-656.
88. Tsuda M, Suzuki T, Misawa M. Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN-1-27-induced antiseizure effect in diazepam-withdrawn mice. Life Sci. 1998;62: PL213-PL217.
89. Frye CA, Paris JJ, Rhodes ME. Increasing 3α,5α-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats. Reproduction. 2009;137:119-128.
90. Barnea ER, Fares F, Gavish M. Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol Cell Endocrinol. 1989;64:155-159.
91. Weizman R, Leschiner S, Schlegel W, Gavish M. Peripheral-type benzodiazepine receptor ligands and serum steroid hormones. Brain Res. 1997;772:203-208.
92. Boujrad N, Hudson JR Jr, Papadopoulos V. Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc Natl Acad Sci USA. 1993;90:5728-5731.
93. Knudsen J, Jensen MV, Hansen JK, Faergeman NJ, Neergaard TB, Gaigg B. Role of acylCoA binding protein in acylCoA transport, metabolism and cell signaling. Mol Cell Biochem. 1999;192:95-103.
94. Mandrup S, Jepsen R, Skott H, et al. Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. Biochem J. 1993;290(pt 2):369-374.
95. Gaigg B, Neergaard TB, Schneiter R, et al. Depletion of acylcoenzyme A-binding protein affects sphingolipid synthesis and causes vesicle accumulation and membrane defects in Saccharomyces cerevisiae. Mol Biol Cell. 2001;12:1147-1160.
96. Ohgami RS, Campagna DR, Greer EL, et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005;37:1264-1269.
97. Ohgami RS, Campagna DR, Antiochos B, et al. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood. 2005;106:3625-3631.
98. Lee L, DeBono CA, Campagna DR, Young DC, Moody DB, Fleming MD. Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skin. J Invest Dermatol. 2007;127:16-23.
99. Landrock D, Atshaves BP, McIntosh AL, Landrock KK, Schroeder F, Kier AB. Acyl-CoA binding protein gene ablation induces preimplantation embryonic lethality in mice. Lipids. 2010;45:567-580.
100. Neess D, Bloksgaard M, Bek S, et al. Disruption of the acyl-CoAbinding protein gene delays hepatic adaptation to metabolic changes at weaning. J Biol Chem. 2011;286:3460-3472.
101. Bloksgaard M, Bek S, Marcher AB, et al. The acyl-CoA binding protein is required for normal epidermal barrier function in mice. J Lipid Res. 2012;53:2162-2174.
102. Neess D, Bek S, Bloksgaard M, Marcher AB, Færgeman NJ, Mandrup S. Delayed hepatic adaptation to weaning in ACBP-/-mice is caused by disruption of the epidermal barrier. Cell Rep. 2013;5: 1403-1412.
103. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 1998;139:4991-4997.
104. Palmer M. Cholesterol and the activity of bacterial toxins. FEMS Microbiol Lett. 2004;238:281-289.
105. Baier CJ, Fantini J, Barrantes FJ. Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci Rep. 2011;1:69.
106. Luo X, Sharma D, Inouye H, et al. Cytoplasmic domain of human myelin protein zero likely folded as _-structure in compact myelin. Biophys J. 2007;92:1585-1597.
107. Yang G, Xu H, Li Z, Li F. Interactions of caveolin-1 scaffolding and intramembrane regions containing a CRAC motif with cholesterol in lipid bilayers. Biochim Biophys Acta. 2014;1838: 2588-2599.
108. Herrera JL, Diaz M, Hernández-Fernaud JR, et al. Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer’s disease. J Neurochem. 2011; 116:820-827.
109. West LA, Horvat RD, Roess DA, Barisas BG, Juengel JL, Niswender GD. Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology. 2001;142:502-505.
110. Bogan RL, Davis TL, Niswender GD. Peripheral-type benzodiazepine receptor (PBR) aggregation and absence of steroidogenic acute regulatory protein (StAR)/PBR association in the mitochondrial membrane as determined by bioluminescence resonance energy transfer (BRET). J Steroid Biochem Mol Biol. 2007;104:61-67.
111. Murail S, Robert JC, Coïc YM, et al. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Biochim Biophys Acta. 2008;1778:1375-1381.
112. Korkhov VM, Sachse C, Short JM, Tate CG. Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure. 2010;18:677-687.
113. Bernassau JM, Reversat JL, Ferrara P, Caput D, Lefur G. A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. J Mol Graph. 1993;11:236-244, 235.
114. Delavoie F, Li H, Hardwick M, Robert JC, et al. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry. 2003;42:4506-4519.
115. Midzak A, Papadopoulos V. Binding domain-driven intracellular trafficking of sterols for synthesis of steroid hormones, bile acids and oxysterols. Traffic. 2014;15:895-914.
116. Lin D, Chang YJ, Strauss JF III, Miller WL. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics. 1993;18:643-650.
117. Owen DR, Yeo AJ, Gunn RN, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR 28. J Cereb Blood Flow Metab. 2012;32:1-5.
118. Mizrahi R, Rusjan PM, Kennedy J, et al. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J Cereb Blood Flow Metab. 2012;32:968-972.
119. Costa B, Pini S, Martini C, et al. Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. Psychiatr Genet. 2009;19:110-111.
120. Costa B, Pini S, Gabelloni P, et al. The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology. 2009;150:5438-5445.
121. Mahata B, Zhang X, Kolodziejczyk AA, et al. Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis. Cell Rep. 2014;7:1130-1142.
122. Liu GJ, Middleton RJ, Hatty CR, et al. The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 2014; 24:631-653.
123. Papadopoulos V. On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology. 2014;155: 15-20.
124. Prasad M, Kaur J, Pawlak KJ, Bose M, Whittal RM, Bose HS. Mitochondria-associated endoplasmic reticulum membrane (MAM) regulates steroidogenic activity via steroidogenic acute regulatory protein (StAR)-voltage-dependent anion channel 2 (VDAC2) interaction. J Biol Chem. 2015;290:2604-2616.
125. Selvaraj V, Stocco DM. The changing landscape in translocator protein (TSPO) function [published online 2015]. Trends Endocrinol Metab. Published Online March 20, 2015.
126. Šileikyte J, Blachly-Dyson E, Sewell R, et al. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (TSPO). J Biol Chem. 2014;289:13769-13781.